Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Gene therapy for ovarian carcinoma.

Robertson MW 3rd, Barnes MN, Rancourt C, Wang M, Grim J, Alvarez RD, Siegal GP, Curiel DT.

Semin Oncol. 1998 Jun;25(3):397-406. Review.

PMID:
9633852
2.

Targeted gene therapy for ovarian cancer.

Rocconi RP, Numnum TM, Stoff-Khalili M, Makhija S, Alvarez RD, Curiel DT.

Curr Gene Ther. 2005 Dec;5(6):643-53. Review.

PMID:
16457653
3.

Gene therapy and ovarian cancer: a review.

Barnes MN, Deshane JS, Rosenfeld M, Siegal GP, Curiel DT, Alvarez RD.

Obstet Gynecol. 1997 Jan;89(1):145-55. Review.

PMID:
8990458
4.

Gene therapy for ovarian cancer: progress and potential.

Kirby TO, Curiel DT, Alvarez RD.

Hematol Oncol Clin North Am. 2003 Aug;17(4):1021-50. Review.

PMID:
12959190
5.

Gene therapy: ovarian carcinoma as the paradigm.

Gómez-Navarro J, Siegal GP, Alvarez RD, Curiel DT.

Am J Clin Pathol. 1998 Apr;109(4):444-67. Review.

6.

Gene directed enzyme prodrug therapy for ovarian cancer: could GDEPT become a promising treatment against ovarian cancer?

Nawa A, Tanino T, Luo C, Iwaki M, Kajiyama H, Shibata K, Yamamoto E, Ino K, Nishiyama Y, Kikkawa F.

Anticancer Agents Med Chem. 2008 Feb;8(2):232-9. Review.

PMID:
18288924
7.

Addressing the challenge: current and future directions in ovarian cancer therapy.

Kaur T, Slavcev RA, Wettig SD.

Curr Gene Ther. 2009 Dec;9(6):434-58. Review.

PMID:
20021329
8.

Drug resistance in ovarian cancer: the emerging importance of gene transcription and spatio-temporal regulation of resistance.

Richardson A, Kaye SB.

Drug Resist Updat. 2005 Oct;8(5):311-21. Epub 2005 Oct 17. Review.

PMID:
16233989
9.

Transcriptional targeting for ovarian cancer gene therapy.

Casado E, Nettelbeck DM, Gomez-Navarro J, Hemminki A, Gonzalez Baron M, Siegal GP, Barnes MN, Alvarez RD, Curiel DT.

Gynecol Oncol. 2001 Aug;82(2):229-37. Review.

PMID:
11531272
10.

[Gene therapy and ovarian cancer: update of clinical trials].

Collinet P, Lanvin D, Vereecque R, Quesnel B, Querleu D.

J Gynecol Obstet Biol Reprod (Paris). 2000 Oct;29(6):532-7. Review. French.

11.

Gene transfer in ovarian cancer cells: a comparison between retroviral and lentiviral vectors.

Indraccolo S, Habeler W, Tisato V, Stievano L, Piovan E, Tosello V, Esposito G, Wagner R, Uberla K, Chieco-Bianchi L, Amadori A.

Cancer Res. 2002 Nov 1;62(21):6099-107.

12.

Genetic changes in the evolution of multidrug resistance for cultured human ovarian cancer cells.

Buys TP, Chari R, Lee EH, Zhang M, MacAulay C, Lam S, Lam WL, Ling V.

Genes Chromosomes Cancer. 2007 Dec;46(12):1069-79.

PMID:
17726699
13.

[Present status and future prospects of human gene therapy].

Shimada T.

Nihon Kyobu Shikkan Gakkai Zasshi. 1993 Dec;31 Suppl:1-4. Japanese.

PMID:
8007452
14.

Treatment of ovarian cancer: new strategies.

DiSaia PJ, Bloss JD.

Gynecol Oncol. 2003 Aug;90(2 Pt 2):S24-32. Review.

PMID:
12928003
15.

Viral-mediated gene transfer for cancer treatment.

Wilson DR.

Curr Pharm Biotechnol. 2002 Jun;3(2):151-64. Review.

PMID:
12022258
16.

[Biologic therapy and epithelial ovarian cancer].

Porpiglia M, Vicelli R, Durando A, Fracchioli S, Puopolo M, Katsaros D, Bellino R, Benedetto C.

Minerva Ginecol. 2004 Feb;56(1):91-104. Review. Italian.

PMID:
14973413
17.

Cancer-specific gene therapy.

Lo HW, Day CP, Hung MC.

Adv Genet. 2005;54:235-55. Review.

PMID:
16096014
18.

From gene therapy to virotherapy for ovarian cancer.

Stoff-Khalili MA, Dall P, Curiel DT.

Minerva Ginecol. 2004 Dec;56(6):503-14. Review.

PMID:
15729203
19.

Gene therapy for ovarian cancer.

Kimball KJ, Numnum TM, Rocconi RP, Alvarez RD.

Curr Oncol Rep. 2006 Nov;8(6):441-7. Review.

PMID:
17040622
20.

Somatic gene therapy. Present situation and future perspective.

Gottschalk U, Chan S.

Arzneimittelforschung. 1998 Nov;48(11):1111-20. Review.

PMID:
9850435
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk